-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Barrett's esotherape (BE), the scaly end of the esotheria, produces a columnal superseed with cup cells, most commonly seen in patients with chronic gastroesoesopause reflow.
Barrett's esophageal is the only definitive pre-cancer lesions of esophageal cancer.
current understanding of the risk of tumor progression in Patients with Barrett esotrachea (BE-IND) carrying uncertain heterogeneous growth (IND) is derived from small retrospective and pathological registration studies.
study is a multi-center queue study designed to determine tumor incidence in patients with BE-IND.
study process included patients diagnosed with BE-IND from two academic centers who received endoscopic follow-up (FU) of up to 1 year or more if there was no evidence of heterogeneity in the past.
1997-2017, 465 BE-IND patients were screened and 223 (48.0%) excluded.
of the 242 patients included in the analysis, 184 (76.0%) did not see heterogeneity during follow-up.
23 cases (9.5%) of patients with tumors (low-level heterogeneous growth (LGD) 20 cases, highly heterogenous growth (HGD) 2 cases, mucous endometrial cancer (IMC) 1 case); After 1.5 years (IQR 0.6-3.2 years), 35 (14.5%) new tumors (LGD 27, HGD 5, IMC 3).
BE length and tumor occurrence all tumors and HGD/IMC incidence rates were 3.2 cases... Nebula Source: MedSci Original Copyright Notice: All text, images and audio and video materials on this website that state "Source: Mets Medicine" or "Source: MedSci Originals" are owned by Mets Medical and are not reproduced by any media, website or individual without authorization, and must be reproduced with the words "Source: Mets Medicine".
all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
reproduce content at the same time does not represent the position of this site.
leave a message here
